A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-021-01442-6

PubMed Identifier: 34172930

Publication URI: http://europepmc.org/abstract/MED/34172930

Type: Journal Article/Review

Volume: 125

Parent Publication: British journal of cancer

Issue: 5

ISSN: 0007-0920